Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01947140
Title Pralatrexate + Romidepsin in Relapsed/Refractory Lymphoid Malignancies (PDX+Romi)
Recruitment Unknown status
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Enrica Marchi
Indications

multiple myeloma

lymphoma

Therapies

Pralatrexate + Romidepsin

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.